Randomization
®
Participants enrolled in the study were assigned (1:1) to the SOC VL testing at the PRL using Roche COBAS® Ampliprep®/COBAS Taqman48® HIV-1 v 2.0 or to the intervention, a clinic-based VL assay, the SAMBA II semi-Q assay (Diagnostics for the Real World, Sunnyvale California) [